A new study shows that TERT, a component of telomerase, shuttles between nuclear compartments during the cell cycle. TERT localization is disrupted in cancer and following ionizing radiation, perhaps affecting genome stability.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Gene expression changes with age in skin, adipose tissue, blood and brain
Genome Biology Open Access 26 July 2013
-
RNA interference-mediated c-MYC inhibition prevents cell growth and decreases sensitivity to radio- and chemotherapy in childhood medulloblastoma cells
BMC Cancer Open Access 10 January 2009
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Maser, R.S. & DePinho, R.A. Connecting chromosomes, crisis, and cancer. Science 297, 565–569 (2002).
Wong, J.M.Y., Kusdra, L. & Collins, K. Subnuclear shuttling of human telomerase induced by transformation and DNA damage. Nat. Cell. Biol. 4, 731–736 (2002).
Ford, L.P., Wright, W.E. & Shay, J.W. A model for heterogeneous nuclear ribonucleoproteins in telomere and telomerase regulation. Oncogene 21, 580–583 (2002).
Ducrest, A.L., Szutorisz, H., Lingner, J. & Nabholz, M. Regulation of the human telomerase reverse transcriptase gene. Oncogene 21, 541–552 (2002).
Colgin, L.M. et al. The hTERTα splice variant is a dominant negative inhibitor of telomerase activity. Neoplasia 2, 426–432 (2000).
Yi, X. et al. An alternate splicing variant of the human telomerase catalytic subunit inhibits telomerase activity. Neoplasia 2, 433–440 (2000).
Ulaner, G.A. et al. Regulation of telomerase by alternate splicing of human telomerase reverse transcriptase (hTERT) in normal and neoplastic ovary, endometrium and myometrium. Int. J. Cancer 85, 330–335 (2000).
Kyo, S. & Inoue, M. Complex regulatory mechanisms of telomerase activity in normal and cancer cells: How can we apply them for cancer therapy? Oncogene 21, 688–697 (2002).
Kharbanda, S. et al. Regulation of the hTERT telomerase catalytic subunit by the c-Abl tyrosine kinase. Curr. Biol. 10, 568–575 (2000).
Akiyama, M. et al. Cytokines modulate telomerase activity in a human multiple myeloma cell line. Cancer Res. 62, 3876–3882 (2002).
Schulz, V.P. & Zakian, V.A. The Saccharomyces PIF1 DNA helicase inhibits telomere elongation and de novo telomere formation. Cell 76, 145–155 (1994).
Myung, K., Chen, C. & Kolodner, R.D. Multiple pathways cooperate in the suppression of genome instability in Saccharomyces cerevisiae. Nature 411, 1073–1076 (2001).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Maser, R., DePinho, R. Keeping telomerase in its place. Nat Med 8, 934–936 (2002). https://doi.org/10.1038/nm0902-934
Issue Date:
DOI: https://doi.org/10.1038/nm0902-934